Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl

Journal of Experimental Medicine

Volumn 183, Issue 3, 1996, Pages 811-820

  Carlesso, Nadia ^b   Frank, David A ^b   Griffin, James D ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRANSFORMATION; DNA BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TEMPERATURE SENSITIVE MUTANT; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; CELL LINE; CELL LINE, TRANSFORMED; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELLS; HL-60 CELLS; HUMANS; MILK PROTEINS; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN-TYROSINE KINASES; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0029863169     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.3.811     Document Type: Article

References (51)

1. Nowell, P.C., and D.A. Hungerford. 1960. A minute chromosome in human chronic granulocytic leukemia. Science (Wash. DC). 132:1497.
2. Rowley, J.D. 1973. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa banding. Nature (Lond.). 243: 290-291.
3. Konopka, J.B., S.M. Watanabe, and O.N. Witte. 1984. An alteration of the human c-abl protein in K562 unmasks associated tyrosine kinase activity. Cell. 37:1035-1042.
4. Konopka, J.B., and O.N. Witte. 1985. Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl products. Mol. Cell. Biol. 5:3116-3123.
5. Daley, G.Q., R.A. Van Etten, and D. Baltimore. 1990. Induction of chronic myelogenous leukemia in mice by the p210Bcr/Abl gene of the Philadelphia chromosome. Science (Wash. DC). 247:824-830.
6. Daley, G.Q., and D. Baltimore. 1988. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl. Proc. Natl Acad. Sci. USA. 85:9312-9316.
7. Gishizky, M.L., and O.N. Witte. 1992. Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro. Science (Wash. DC). 256:836-839.
8. McLaughlin, J., E. Chianese, and O N. Witte. 1987. In vitro transformation of immature hematopoietic cells by the p210Bcr/Abl oncogene product of the Philadelphia chromosome. Proc. Natl. Acad. Sci. USA. 84:6558-6562.
9. Young, J.C., and O.N. Witte. 1988. Selective transformation of primitive lymphoid cells by the Bcr/Abl oncogene expressed in long-term lymphoid or myeloid cultures. Mol. Cell. Biol. 8:4079-4087.
10. Metcalf, D., C.G. Begley, G.R. Johnson, N.A. Nicola, A.F. Lopez, and D.J. Williamson. 1986. Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal mice. Blood. 68:46-57.
11. Broxmeyer, H.E., D.E. Williams, S. Cooper, R.W. Shadduck, S. Gillis, A. Waheed, D.L. Urdal, and D.C. Bicknell. 1987. Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice. J. Clin. Invest. 79:721-730.
12. Wong, P.M., S.W. Chung, C.E. Dunbar, and D.M. Bodine. 1989. Retrovirus-mediated transfer and expression of the interleukin-3 gene in mouse hematopoietic cells result in a myeloproliferative disorder. Mol. Cell. Biol. 9:798-808.
13. Matulonis, U., R. Salgia, K. Okuda, B. Druker, and J.D. Griffin. 1993. IL-3 and p21bcr/abl activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line. Exp. Hematol. 21:1460-1466.
14. Matsuguchi, T., R. Salgia, M. Hallek, M. Eder, B. Druker, T. Ernst, and J.D. Griffin. 1994. She phosphorylation in myeloid cells is regulated by granulocyte macrophage colony stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210Bcr/Abl. J. Biol. Chem. 269: 5016-5021.
15. Matsuguchi, T., R. Inhorn, N. Carlesso, G. Xu, B. Druker, and J.D. Griffin. 1995. Tyrosine phosphorylation of p955VAV in myeloid cells is regulated by GM-CSF, IL-3, and Steel factor and is constitutively increased by p210Bcr/Abl. EMBO (Eur. Mol. Biol. Organ.) J. 14:257-265.
16. Ernst, T.J., K.E. Slattery, and J.D. Griffin. 1994. p210Bcr/ Abl and p160v-Abl induce and increase in the tyrosine phosphorylauon of p93c-Fes. J. Biol. Chem. 269:5764-5769.
17. Salgia, R., J.L. Li, S.H. Lo, B. Brunkhorst, G.S. Kansas, E.S. Sobhany, Y. Sun, E. Pisick, M. Hallek, T. Ernst, et al. 1995. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by p210Bcr/Abl. J. Biol. Chem. 270:5039-5047.
18. Tauchi, T., G.S. Feng, R. Shen, H.Y. Song, D. Donner, T. Pawson, and H.E. Broxmeyer. 1994. SH2-containing phosphotyrosine phosphatase Syp is a target of p210Bcr/Abl tyrosine kinase. J. Biol. Chem. 269:15381-15387.
19. Darnell, J.E., Jr., I.M. Kerr, and G.R. Stark. 1994. JAK-STAT pathways and transcriptional activation in response to IFNs and other extra-cellular signaling proteins. Science (Wash. DC). 264:1415-1421.
20. Ihle, J.N., B.A. Witthuhn, F. W. Quelle, K. Yamamoto, W.E. Thierfelder, B. Kreider, and O. Silvennoinen. 1994. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci. 19:222-227.
21. Schindler, C., K. Shuai, V.R. Prezioso, and J.E. Darnell, Jr. 1992. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science (Wash. DC). 257:809-813.
22. Shuai, K., C. Schindler, V.R. Prezioso, and J.E. Darnell, Jr. 1992. Activation of transcription by IFNγ: tyrosine phosphorylation of a 91 kD DNA binding protein. Science (Wash. DC). 259:1808-1812.
23. Shuai, K., G.R. Stark, I.M. Kerr, and J.E. Darnell, Jr. 1993. A single phosphotyrosine residue of STAT91 required for gene activation by interferon-γ. Science (Wash. DC). 261: 1744-1746.
24. Shuai, K., A. Ziemiecki, A.F. Wilks, A.G. Harpur, H.B. Sadowski, M.Z. Gilman, and J.E. Darnell, Jr. 1993. Polypeptide signaling to the nucleus through tyrosine phosphorylation of JAK and STAT proteins. Nature (Lond.). 366:580.
25. Mui, A.L.-F., H. Wakao, A.M. O'Farrell, N. Harada, and A. Miyajima. 1995. Interleukin-3, granlocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STATS homologs. EMBO (Eur. Mol. Biol. Organ.) J. 14:1166-1175.
26. Quelle, F.W., K. Shimoda, W. Thierfelder, C. Fischer, A. Kim, S.M. Ruben, J. Cleveland, J.H. Pierce, A.D. Keegan, K. Nelms, et al. 1995. Cloning of murine STAT6 and human STAT6, STAT proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15:3336-3343.
27. Brizzi, M.F., M.G. Aronica, A. Rosso, P. Dentelli, Y. Yarden, and L. Pegoraro. Granulocyte-macrophage colony stimulating factor (GM-CSF) stimulates JAK2 signaling pathway and rapidly activates p93fes, STAT1 p91 and STAT3 p92 in polymorphonuclear leukocytes. J. Biol. Chem. In press.
28. Quelle, F.W., N. Sato, B.A. Witthuhn, R.C. Inborn, M. Eder, A. Miyajima, J.D. Griffin, and J.N. Ihle. 1994. JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane proximal region. Mol. Cell. Biol. 14: 4335-4341.
29. Greenberger, J.S., M.A. Sakakeeny, R.K. Humphries, C.J. Eaves, and R.J. Eckner. 1983. Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc. Natl. Acad. Sci. USA. 80:2931-2935.
30. Palacios, R., and M. Steinmetz. 1985. IL-3 - dependent mouse clones that express B-220 antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell. 41:727-734.
31. Pegoraro, L., L. Matera, J. Ritz, A. Lewis, A. Palumbo, and G. Biagini. 1983. Establishment of a Phi-positive human cell line (BV173).J. Natl. Cancer Inst. 70:447-453.
32. Beckwith, M., D.L. Longo, C.D. O'Connell, C.M. Moratz, and W.J. Urba. 1990. Phorbol ester-induced, cell cycle-specific, growth inhibition of human B-lymphoma cell lines. J. Natl. Cancer Inst. 82:501-509.
33. Minowada, J., G. Janossy, M.F. Greaves, T. Tsubota, B.I. Srivastava, S. Morikawa, and E. Tatsumi. 1978. Expression of an antigen associated with acute lymphoblastic leukemia in human leukemia-lymphoma cell lines. J. Natl. Cancer Inst. 60: 1269-1277.
34. Kitamura, T., T. Tange, T. Teresawa, S. Chiba, T. Kawai, K. Miyagama, Y.F. Piao, K. Miyazono, A. Urabe, and F. Takaku. 1989. Establishment and characterization of a unique human cell line that proliferates dependendy on GM-CSF, IL-3 or erythropoietin. J. Cell. Physiol. 140:323-334.
35. Lozzio, C.B., and B.B. Lozzio. 1975. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood. 45:321-334.
36. Collins, S.J., R.C. Gallo, and R.E. Gallagher. 1977. Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature (Lond.). 270:347-349.
37. Sundstrom, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocitic lymphoma cell line. Int. J. Cancer. 17:565-577.
38. Carlesso, N., J.D. Griffin, and B. Druker. 1994. Use of a temperature-sensitive mutant to define the biological effects of the p210Bcr/Abl tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line. Oncogene. 9:149-156.
39. Frank, D.A., M.J. Robertson, A. Bonni, J. Ritz, and M.E. Greenberg. 1995. Interleukin 2 signaling involves the phosphorylation of STAT proteins. Proc. Natl. Acad. Sci. USA. 92: 7779-7783.
40. Kanakura, Y., B. Druker, S.A. Cannistra, Y. Furukawa, Y. Torimoto, and J.D. Griffin. 1990. Signal transduction of the human granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins. Blood. 76:706-715.
41. Kabarovsky, J.H.S., P.B. Allen, and L.M. Wiedemann. 1994. A temperature sensitive p210Bcr/Abl mutant defines the primary consequences of Bcr/Abl tyrosine kinase expression in growth factor dependent cells. EMBO (Eur. Mol. Biol. Organ.) J. 13:5887-5895.
42. Sirard, C., P. Laneuville, and J.E. Dick. 1994. Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic MO7E cells by an autocrine mechanism. Blood. 83:1575-1585.
43. Laneuville, P., N. Heisterkamp, and J. Goeffen. 1991 Expression of the chronic myelogenous leukemia - associated p210Bcr/Abl oncoprotein in a murine IL-3 dependent myeloid cell line. Oncogene. 6:275-282.
44. Bonni, A., D.A. Frank, C. Schindler, and M.E. Greenberg. 1993. Characterization of a pathway for ciliary neurotrophic factor signaling to the nucleus. Science (Wash. DC). 262: 1575-1579.
45. Migone, T.S., J.-X. Lin, A. Cereseto, J.C. Mulloy, J.J. O'Shea, G. Franchini, and W.J. Leonard. 1995. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1. Science (Wash. DC). 269:79-81.
46. Yu, C.-L., D.J. Meyer, G.S. Campbell, A.C. Larner, C. Carter-Su, J. Schwartz, and R. Jove. 1995. Enhanced DNA-binding activity of a STAT3-related protein in cells transformed by the Src oncoprotein. Science (Wash. DC). 269:81-83.
47. Fialkow, P.J., J.R. Jacobson, and T. Papayannopoulou. 1977. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am. J. Med. 63:125-130.
48. Eaves, C.J., and A.C. Eaves. 1987. Bailliere's Clinical Haematology: Chronic Myeloid Leukemia. J.M. Goldman, editor. Bailliere Tindall Ltd., London, 931-961.
49. Verfaille, C.M., J.B. McCarthy, and P.B. McGlave. 1992. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. J. Clin. Invest. 90:1232-1241.
50. Laneuville, P., G. Sun, M. Timm, and M. Vekemans. 1992. Clonal evolution in a myeloid cell line transformed to IL-3 independent growth by retroviral transduction and expression of p210bcr/abl. Blood 80:1788-1797.
51. Fu, X.-Y. 1992. A transcription factor with SH2 and SH3 domains is directly activated by an interferon α-induced cytoplasmic protein tyrosine kinase(s). Cell. 70:323-335.